Topchoice Medical Co. Statistics
Total Valuation
Topchoice Medical Co. has a market cap or net worth of CNY 18.50 billion. The enterprise value is 19.60 billion.
Market Cap | 18.50B |
Enterprise Value | 19.60B |
Important Dates
The next estimated earnings date is Monday, October 21, 2024.
Earnings Date | Oct 21, 2024 |
Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
Topchoice Medical Co. has 447.29 million shares outstanding. The number of shares has decreased by -0.28% in one year.
Shares Outstanding | 447.29M |
Shares Change (YoY) | -0.28% |
Shares Change (QoQ) | -0.84% |
Owned by Insiders (%) | 3.79% |
Owned by Institutions (%) | 19.63% |
Float | 278.76M |
Valuation Ratios
The trailing PE ratio is 36.68 and the forward PE ratio is 48.09. Topchoice Medical Co.'s PEG ratio is 5.17.
PE Ratio | 36.68 |
Forward PE | 48.09 |
PS Ratio | 6.39 |
PB Ratio | 4.70 |
P/FCF Ratio | 50.41 |
PEG Ratio | 5.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.59, with an EV/FCF ratio of 53.42.
EV / Earnings | 38.75 |
EV / Sales | 6.77 |
EV / EBITDA | 21.59 |
EV / EBIT | 28.00 |
EV / FCF | 53.42 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 32.82.
Current Ratio | 1.42 |
Quick Ratio | 1.32 |
Debt / Equity | 32.82 |
Debt / EBITDA | 1.54 |
Debt / FCF | 3.81 |
Interest Coverage | 12.28 |
Financial Efficiency
Return on equity (ROE) is 14.35% and return on invested capital (ROIC) is 7.97%.
Return on Equity (ROE) | 14.35% |
Return on Assets (ROA) | 7.46% |
Return on Capital (ROIC) | 7.97% |
Revenue Per Employee | 473,331 |
Profits Per Employee | 82,727 |
Employee Count | 6,115 |
Asset Turnover | 0.49 |
Inventory Turnover | 70.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.27% in the last 52 weeks. The beta is 0.48, so Topchoice Medical Co.'s price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | -39.27% |
50-Day Moving Average | 42.44 |
200-Day Moving Average | 45.98 |
Relative Strength Index (RSI) | 44.30 |
Average Volume (20 Days) | 5,211,019 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Topchoice Medical Co. had revenue of CNY 2.89 billion and earned 505.87 million in profits. Earnings per share was 1.13.
Revenue | 2.89B |
Gross Profit | 1.11B |
Operating Income | 699.97M |
Pretax Income | 714.85M |
Net Income | 505.87M |
EBITDA | 793.36M |
EBIT | 699.97M |
Earnings Per Share (EPS) | 1.13 |
Balance Sheet
The company has 623.14 million in cash and 1.40 billion in debt, giving a net cash position of -776.00 million or -1.73 per share.
Cash & Cash Equivalents | 623.14M |
Total Debt | 1.40B |
Net Cash | -776.00M |
Net Cash Per Share | -1.73 |
Equity (Book Value) | 4.26B |
Book Value Per Share | 8.80 |
Working Capital | 266.83M |
Cash Flow
In the last 12 months, operating cash flow was 869.88 million and capital expenditures -502.93 million, giving a free cash flow of 366.95 million.
Operating Cash Flow | 869.88M |
Capital Expenditures | -502.93M |
Free Cash Flow | 366.95M |
FCF Per Share | 0.82 |
Margins
Gross margin is 38.32%, with operating and profit margins of 24.18% and 17.48%.
Gross Margin | 38.32% |
Operating Margin | 24.18% |
Pretax Margin | 24.70% |
Profit Margin | 17.48% |
EBITDA Margin | 27.41% |
EBIT Margin | 24.18% |
FCF Margin | 12.68% |
Dividends & Yields
This stock pays an annual dividend of 0.31, which amounts to a dividend yield of 0.75%.
Dividend Per Share | 0.31 |
Dividend Yield | 0.75% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 2.23% |
Buyback Yield | 0.28% |
Shareholder Yield | 1.03% |
Earnings Yield | 2.73% |
FCF Yield | 1.98% |
Stock Splits
The last stock split was on July 5, 2024. It was a forward split with a ratio of 1.400595.
Last Split Date | Jul 5, 2024 |
Split Type | Forward |
Split Ratio | 1.400595 |